References
- Bloudek LM, Stokes M, Buse DC, et al. Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). J Headache Pain. 2012 Jul;13(5):361–378.
- Kurth T, Rist PM, Ridker PM, et al. Association of migraine with aura and other risk factors with incident cardiovascular disease in women. JAMA. 2020 Jun 9;323(22):2281–2289.
- Rockett FC, Perla Ada S, Perry ID, et al. Cardiovascular disease risk in women with migraine. J Headache Pain. 2013 Sep 6;14:75.
- Winsvold BS, Hagen K, Aamodt AH, et al. Headache, migraine and cardiovascular risk factors: the HUNT study. Eur J Neurol. 2011 Mar;18(3):504–511.
- Oie LR, Kurth T, Gulati S, et al. Migraine and risk of stroke. J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):593–604.
- Spector JT, Kahn SR, Jones MR, et al. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med. 2010 Jul;123(7):612–624.
- Tana C, Santilli F, Martelletti P, et al. Correlation between migraine severity and cholesterol levels. Pain Pract. 2015 Sep;15(7):662–670.
- Liampas I, Mylonas KS, Brotis A, et al. Serum lipid abnormalities in migraine: a meta-analysis of observational studies. Headache. 2021 Jan;61(1):44–59.
- Rist PM, Tzourio C, Kurth T. Associations between lipid levels and migraine: cross-sectional analysis in the epidemiology of vascular ageing study. Cephalalgia. 2011 Oct;31(14):1459–1465.
- Aslan G, Sade LE, Yetis B, et al. Flow in the left anterior descending coronary artery in patients with migraine headache. Am J Cardiol. 2013 Nov 15;112(10):1540–1544.
- Gruber HJ, Bernecker C, Pailer S, et al. Lipid profile in normal weight migraineurs - evidence for cardiovascular risk. Eur J Neurol. 2010 Mar;17(3):419–425.
- Yilmaz Avci A, Akkucuk MH, Torun E, et al. Migraine and subclinical atherosclerosis: endothelial dysfunction biomarkers and carotid intima-media thickness: a case-control study. Neurol Sci. 2019 Apr;40(4):703–711.
- Assarzadegan F, Hosseinpanahi SP, Hesami O, et al. Frequency of dyslipidemia in migraineurs in comparison to control group. J Family Med Prim Care. 2019 Mar;8(3):950–954.
- Eren Y, Dirik EB, Neşelioğlu S, et al. Serum lipid profiles, relationship between paraoxonase/arylesterase activity and high-density lipoprotein levels in patients with migraine. Turk J Neurol. 2017;23(3):117–121.
- Ge W, Gao L, Zhang Y, et al. Association between serum lipid levels and severe headache or migraine in representative American population: a cross-sectional study. Curr Neurovasc Res. 2021;18(3):333–342.
- Scher AI, Terwindt GM, Picavet HS, et al. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology. 2005 Feb 22;64(4):614–620.
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972 Jun;18(6):499–502.
- Khan MM, Shil SK, Hossain S, et al. Study of association of serum lipid levels with migraine. J Enam Med Coll. 2020;10(1):27–32.
- Celikbilek A, Borekci E, Kozan M, et al. Assessment of met- abolic syndrome in patients with migraine in Central Anatolia. Eur J Gen Med. 2015;12(2):152–156.
- Ulusoy EK. Correlations between the monocyte to high-density lipoprotein cholesterol ratio and white matter hyperintensities in migraine. Neurol Res. 2020 Feb;42(2):126–132.
- Feng L, Nian S, Tong Z, et al. Age-related trends in lipid levels: a large-scale cross-sectional study of the general Chinese population. BMJ Open. 2020 Mar 18;10(3):e034226.
- Gruber HJ, Bernecker C, Lechner A, et al. Increased nitric oxide stress is associated with migraine. Cephalalgia. 2010 Apr;30(4):486–492.
- Yilmaz G, Sürer H, Inan LE, et al. Increased nitrosative and oxidative, stress in platelets of migraine patients. TJEM 2007 Jan; 211(1): 23–30.
- Bockowski L, Sobaniec W, Kulak W, et al. Serum and intraerythrocyte antioxidant enzymes and lipid peroxides in children with migraine. Pharmacol Rep. 2008 Jul-Aug;60(4):542–548.
- Yilmaz N, Aydin O, Yegin A, et al. Increased levels of total oxidant status and decreased activity of arylesterase in migraineurs. Clin Biochem. 2011 Jul;44(10–11):832–837.
- Yildirim S, Akar S, Kuyucu M, et al. Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine. Cell Biochem Funct. 2011 Oct;29(7):549–554.
- Guldiken B, Guldiken S, Demir M, et al. Low leptin levels in migraine: a case control study. Headache. 2008 Jul;48(7):1103–1107.
- Guldiken B, Demir M, Guldiken S, et al. Asymmetric dimethylarginine and nitric oxide levels in migraine during the interictal period. J Clin Neurosci. 2009 May;16(5):672–674.
- Fava A, Pirritano D, Consoli D, et al. Chronic migraine in women is associated with insulin resistance: a cross-sectional study. Eur J Neurol. 2014 Feb;21(2):267–272.